The infusion therapy devices market size has grown rapidly in recent years. It will grow from $13.33 billion in 2025 to $14.74 billion in 2026 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to increasing prevalence of chronic diseases, rising hospital admissions requiring infusion therapy, expansion of oncology and diabetes treatments, growing use of intravenous drug delivery, improved availability of infusion devices.
The infusion therapy devices market size is expected to see rapid growth in the next few years. It will grow to $21.82 billion in 2030 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to increasing demand for home healthcare services, rising adoption of connected medical devices, expansion of personalized medicine delivery, growing focus on reducing medication errors, increasing investments in smart hospital infrastructure. Major trends in the forecast period include increasing adoption of smart infusion pumps, rising demand for portable and ambulatory infusion devices, growing integration of dose error reduction systems, expansion of home-based infusion therapy, enhanced focus on patient safety and monitoring.
The rising incidence of chronic diseases is anticipated to drive the growth of the infusion therapy devices market. Chronic diseases, which are long-term health conditions lasting over a year and requiring continuous medical attention or limiting daily activities, are becoming more common due to factors such as poor lifestyle choices, sedentary habits, unhealthy diets, environmental influences, and risk factors such as obesity, smoking, and stress. Infusion therapy devices help manage these conditions by delivering medications and fluids directly into the bloodstream in a precise and controlled manner, ensuring effective treatment for conditions such as diabetes, autoimmune disorders, and cancer. This approach enhances patient outcomes, increases convenience, and reduces the need for frequent hospital visits. For example, a report from the National Center for Biotechnology Information (NCBI) in January 2023 projected that by 2050, the number of individuals over the age of 50 with at least one chronic illness will increase by 99.5%, from 71.522 million in 2020 to 142.66 million. As a result, the growing prevalence of chronic diseases is contributing to the market expansion of infusion therapy devices.
Companies in the infusion therapy devices market are focusing on innovations such as pressure-enabled drug delivery (PEDD) technology to improve treatments for liver and pancreatic tumors. PEDD is a technology that uses pressure to enhance the infusion of therapeutic agents into tissues or organs, particularly in cases where traditional methods may not be as effective. In November 2024, TriSalus Life Sciences, a US-based medical technology company, introduced the TriNav LV Infusion System and TriGuide Guiding Catheters, expanding its PEDD portfolio to improve therapeutic delivery and potentially enhance treatment outcomes. The TriNav LV Infusion System offers features such as accommodating larger blood vessels (3.5 to 5 mm), which broadens the patient population eligible for PEDD technology. This launch increases device compatibility from 1.5 mm to 5 mm vessels, providing more treatment options for interventional radiologists. The TriGuide Guiding Catheters have a larger inner diameter, a lubricious lining, and a reverse curve design, improving femoral access and procedural efficiency. Early users report a 97% satisfaction rate, highlighting the system's effectiveness and ease of use in oncology treatments.
In July 2024, ICU Medical Inc., a US-based medical technology company, acquired Smiths Medical Inc. for an undisclosed sum. This acquisition aims to strengthen ICU Medical’s infusion therapy product line and expand its portfolio into new clinical care markets, offering a more comprehensive range of infusion systems and related products. Smiths Medical Inc. is a US-based manufacturer of medical devices, including infusion therapy devices.
Major companies operating in the infusion therapy devices market are Roche Holding AG, Fresenius Kabi AG, Medtronic plc, Medline Industries Inc., Baxter International Inc., Terumo Corporation, Mindray Medical International Limited, Nipro Corporation, ICU Medical Inc., Cook Medical, LivaNova PLC, Vygon S.A., AngioDynamics Inc., B. Braun Melsungen AG, Moog Medical Devices Group, Kangaroo, Vantage Medical Technologies, Alaris Medical Systems Inc., Smiths Medical, Teleflex Incorporated.
North America was the largest region in the infusion therapy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infusion therapy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the infusion therapy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the infusion therapy devices market by increasing the cost of imported electronic components, sensors, precision plastics, and medical-grade materials used in infusion pumps, IV sets, and needleless connectors. Hospitals and homecare providers in North America and Europe are most affected due to reliance on imported high-precision components, while Asia-Pacific faces higher manufacturing input costs. These tariffs are raising procurement expenses and affecting device replacement cycles. However, they are also encouraging localized manufacturing, regional supply chain diversification, and increased investment in domestic production of infusion therapy devices.
The infusion therapy devices market research report is one of a series of new reports that provides infusion therapy devices market statistics, including infusion therapy devices industry global market size, regional shares, competitors with a infusion therapy devices market share, detailed infusion therapy devices market segments, market trends and opportunities, and any further data you may need to thrive in the infusion therapy devices industry. This infusion therapy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Infusion therapy devices are medical tools used to administer fluids, medications, nutrients, or blood products directly into a patient's bloodstream. These devices are highly versatile, enhancing patient care by ensuring the accurate and controlled delivery of fluids, medications, and nutrition.
The main types of infusion therapy devices include intravenous (IV) sets, cannulas, and needleless connectors. Infusion pumps are specialized devices that deliver controlled amounts of fluids, medications, or nutrients into a patient's body. These pumps come in various mobility options, such as portable and stationary pumps, and are used for different applications including oncology, diabetes, pain management, and more. They serve a wide range of end users, including hospitals, clinics, ambulatory surgical centers, home care settings, and others.
The infusion therapy devices market consists of sales of products including pumps, catheters, sets, ports, and accessories. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The infusion therapy devices market size is expected to see rapid growth in the next few years. It will grow to $21.82 billion in 2030 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to increasing demand for home healthcare services, rising adoption of connected medical devices, expansion of personalized medicine delivery, growing focus on reducing medication errors, increasing investments in smart hospital infrastructure. Major trends in the forecast period include increasing adoption of smart infusion pumps, rising demand for portable and ambulatory infusion devices, growing integration of dose error reduction systems, expansion of home-based infusion therapy, enhanced focus on patient safety and monitoring.
The rising incidence of chronic diseases is anticipated to drive the growth of the infusion therapy devices market. Chronic diseases, which are long-term health conditions lasting over a year and requiring continuous medical attention or limiting daily activities, are becoming more common due to factors such as poor lifestyle choices, sedentary habits, unhealthy diets, environmental influences, and risk factors such as obesity, smoking, and stress. Infusion therapy devices help manage these conditions by delivering medications and fluids directly into the bloodstream in a precise and controlled manner, ensuring effective treatment for conditions such as diabetes, autoimmune disorders, and cancer. This approach enhances patient outcomes, increases convenience, and reduces the need for frequent hospital visits. For example, a report from the National Center for Biotechnology Information (NCBI) in January 2023 projected that by 2050, the number of individuals over the age of 50 with at least one chronic illness will increase by 99.5%, from 71.522 million in 2020 to 142.66 million. As a result, the growing prevalence of chronic diseases is contributing to the market expansion of infusion therapy devices.
Companies in the infusion therapy devices market are focusing on innovations such as pressure-enabled drug delivery (PEDD) technology to improve treatments for liver and pancreatic tumors. PEDD is a technology that uses pressure to enhance the infusion of therapeutic agents into tissues or organs, particularly in cases where traditional methods may not be as effective. In November 2024, TriSalus Life Sciences, a US-based medical technology company, introduced the TriNav LV Infusion System and TriGuide Guiding Catheters, expanding its PEDD portfolio to improve therapeutic delivery and potentially enhance treatment outcomes. The TriNav LV Infusion System offers features such as accommodating larger blood vessels (3.5 to 5 mm), which broadens the patient population eligible for PEDD technology. This launch increases device compatibility from 1.5 mm to 5 mm vessels, providing more treatment options for interventional radiologists. The TriGuide Guiding Catheters have a larger inner diameter, a lubricious lining, and a reverse curve design, improving femoral access and procedural efficiency. Early users report a 97% satisfaction rate, highlighting the system's effectiveness and ease of use in oncology treatments.
In July 2024, ICU Medical Inc., a US-based medical technology company, acquired Smiths Medical Inc. for an undisclosed sum. This acquisition aims to strengthen ICU Medical’s infusion therapy product line and expand its portfolio into new clinical care markets, offering a more comprehensive range of infusion systems and related products. Smiths Medical Inc. is a US-based manufacturer of medical devices, including infusion therapy devices.
Major companies operating in the infusion therapy devices market are Roche Holding AG, Fresenius Kabi AG, Medtronic plc, Medline Industries Inc., Baxter International Inc., Terumo Corporation, Mindray Medical International Limited, Nipro Corporation, ICU Medical Inc., Cook Medical, LivaNova PLC, Vygon S.A., AngioDynamics Inc., B. Braun Melsungen AG, Moog Medical Devices Group, Kangaroo, Vantage Medical Technologies, Alaris Medical Systems Inc., Smiths Medical, Teleflex Incorporated.
North America was the largest region in the infusion therapy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infusion therapy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the infusion therapy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the infusion therapy devices market by increasing the cost of imported electronic components, sensors, precision plastics, and medical-grade materials used in infusion pumps, IV sets, and needleless connectors. Hospitals and homecare providers in North America and Europe are most affected due to reliance on imported high-precision components, while Asia-Pacific faces higher manufacturing input costs. These tariffs are raising procurement expenses and affecting device replacement cycles. However, they are also encouraging localized manufacturing, regional supply chain diversification, and increased investment in domestic production of infusion therapy devices.
The infusion therapy devices market research report is one of a series of new reports that provides infusion therapy devices market statistics, including infusion therapy devices industry global market size, regional shares, competitors with a infusion therapy devices market share, detailed infusion therapy devices market segments, market trends and opportunities, and any further data you may need to thrive in the infusion therapy devices industry. This infusion therapy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Infusion therapy devices are medical tools used to administer fluids, medications, nutrients, or blood products directly into a patient's bloodstream. These devices are highly versatile, enhancing patient care by ensuring the accurate and controlled delivery of fluids, medications, and nutrition.
The main types of infusion therapy devices include intravenous (IV) sets, cannulas, and needleless connectors. Infusion pumps are specialized devices that deliver controlled amounts of fluids, medications, or nutrients into a patient's body. These pumps come in various mobility options, such as portable and stationary pumps, and are used for different applications including oncology, diabetes, pain management, and more. They serve a wide range of end users, including hospitals, clinics, ambulatory surgical centers, home care settings, and others.
The infusion therapy devices market consists of sales of products including pumps, catheters, sets, ports, and accessories. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Infusion Therapy Devices Market Characteristics
3. Infusion Therapy Devices Market Supply Chain Analysis
4. Global Infusion Therapy Devices Market Trends and Strategies
5. Infusion Therapy Devices Market Analysis of End Use Industries
7. Global Infusion Therapy Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Infusion Therapy Devices Total Addressable Market (TAM) Analysis for the Market
9. Infusion Therapy Devices Market Segmentation
10. Infusion Therapy Devices Market Regional and Country Analysis
11. Asia-Pacific Infusion Therapy Devices Market
12. China Infusion Therapy Devices Market
13. India Infusion Therapy Devices Market
14. Japan Infusion Therapy Devices Market
15. Australia Infusion Therapy Devices Market
16. Indonesia Infusion Therapy Devices Market
17. South Korea Infusion Therapy Devices Market
18. Taiwan Infusion Therapy Devices Market
19. South East Asia Infusion Therapy Devices Market
20. Western Europe Infusion Therapy Devices Market
21. UK Infusion Therapy Devices Market
22. Germany Infusion Therapy Devices Market
23. France Infusion Therapy Devices Market
24. Italy Infusion Therapy Devices Market
25. Spain Infusion Therapy Devices Market
26. Eastern Europe Infusion Therapy Devices Market
27. Russia Infusion Therapy Devices Market
28. North America Infusion Therapy Devices Market
29. USA Infusion Therapy Devices Market
30. Canada Infusion Therapy Devices Market
31. South America Infusion Therapy Devices Market
32. Brazil Infusion Therapy Devices Market
33. Middle East Infusion Therapy Devices Market
34. Africa Infusion Therapy Devices Market
36. Infusion Therapy Devices Market Competitive Landscape and Company Profiles
37. Infusion Therapy Devices Market Other Major and Innovative Companies
40. Infusion Therapy Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Infusion Therapy Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses infusion therapy devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for infusion therapy devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The infusion therapy devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Infusion Pumps; Intravenous (Iv) Sets; Cannulas; Needleless Connectors2) By Mobility: Portable Infusion Pumps; Stationary Pumps
3) By Application: Oncology; Diabetes; Pain Management; Other Applications
4) By End-User: Hospitals And Clinics; Ambulatory Surgical Centers; Homecare; Other End-Users
Subsegments:
1) By Infusion Pumps: Volumetric Infusion Pumps; Syringe Infusion Pumps; Ambulatory Infusion Pumps; Insulin Infusion Pumps2) By Intravenous (IV) Sets: Standard IV Sets; Extension IV Sets; IV Administration Sets with Filters
3) By Cannulas: Peripheral Intravenous (PIV) Cannulas; Central Venous Cannulas; Butterfly Cannulas
4) By Needleless Connectors: Positive Pressure Needleless Connectors; Neutral Pressure Needleless Connectors; Negative Pressure Needleless Connectors
Companies Mentioned: Roche Holding AG; Fresenius Kabi AG; Medtronic plc; Medline Industries Inc.; Baxter International Inc.; Terumo Corporation; Mindray Medical International Limited; Nipro Corporation; ICU Medical Inc.; Cook Medical; LivaNova PLC; Vygon S.A.; AngioDynamics Inc.; B. Braun Melsungen AG; Moog Medical Devices Group; Kangaroo; Vantage Medical Technologies; Alaris Medical Systems Inc.; Smiths Medical; Teleflex Incorporated
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Infusion Therapy Devices market report include:- Roche Holding AG
- Fresenius Kabi AG
- Medtronic plc
- Medline Industries Inc.
- Baxter International Inc.
- Terumo Corporation
- Mindray Medical International Limited
- Nipro Corporation
- ICU Medical Inc.
- Cook Medical
- LivaNova PLC
- Vygon S.A.
- AngioDynamics Inc.
- B. Braun Melsungen AG
- Moog Medical Devices Group
- Kangaroo
- Vantage Medical Technologies
- Alaris Medical Systems Inc.
- Smiths Medical
- Teleflex Incorporated
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 14.74 Billion |
| Forecasted Market Value ( USD | $ 21.82 Billion |
| Compound Annual Growth Rate | 10.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
